Allergy Therapeutics (AGY): Corp Implications of PQ Birch Phase III top-line data | Robinson (RBN): Corp A package of upgrades for FY2019E
22 Mar 2019
Morning Note – 22 March 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 22 March 2019
Robinson plc (RBN:LON), 97.5
- Published:
22 Mar 2019 -
Author:
Mark Brewer | Cavendish Research -
Pages:
4
Allergy Therapeutics (AGY): Corp Implications of PQ Birch Phase III top-line data | Robinson (RBN): Corp A package of upgrades for FY2019E